ARCHIVES

NCI, FDA Are Feuding Again, This Time Overcharge That DCT Moved Too Slowly On Toxicity Notification

This article is from The Cancer Letter archive.

Vol. 07 No. 15 | April 10, 1981

Download PDF Visit The Full Archive

Related Articles

In Brief: Walter To Retire, Search Starts For New DEA Deputy; Mary Fink Retires; NCCP Seeks Director

January 27, 1984

In Brief: David Chambers named deputy director for implementation science at NCI DCCPS

December 5, 2014

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

September 29, 2006

Plan To Reprogram $10 Million On Construction Funds Draws Criticism

November 19, 1976

Obit: George Santos, Hopkins Cancer Treatment Pioneer.

January 26, 2001